{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-075235","form_type":"8-K","ticker":"HCWB","cik":"0001828673","company_name":"HCW Biologics Inc.","filed_at":"2025-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.984518+00:00","generated_at":"2026-05-21T00:24:42.218060+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Armistice exercises 177,140 pre-funded warrants; convertible notes converted to insider shares at $7.45","bullets":["Armistice Capital exercised pre-funded warrants for 177,140 shares of common stock on May 15.","Convertible Bridge Notes ($270k principal, 10% PIK, due May 2026) converted at $7.45/share.","CEO Hing C. Wong received 8,054 shares; Chairman Scott Garrett got 13,423 shares.","Director Gary Winer received 1,342 shares; all conversion shares subject to 90-day lockup.","Note holders also get contingent proceeds from future sale of Wugen common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-075235","json":"https://secwatch.observer/filing/0000950170-25-075235.json","markdown":"https://secwatch.observer/filing/0000950170-25-075235.md","text":"https://secwatch.observer/filing/0000950170-25-075235.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025075235/0000950170-25-075235-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025075235/hcwb-20250515.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T00:24:42.218060+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}